Originally published In Press as doi:10.1074/jbc.M001278200 on March 27, 2000
J. Biol. Chem., Vol. 275, Issue 26, 19449-19455, June 30, 2000
Cysteines Involved in Radical Generation and Catalysis of
Class III Anaerobic Ribonucleotide Reductase
A PROTEIN ENGINEERING STUDY OF BACTERIOPHAGE T4 NrdD*
Jessica
Andersson,
MariAnn
Westman,
Margareta
Sahlin, and
Britt-Marie
Sjöberg
From the Department of Molecular Biology, Stockholm University,
SE-10691 Stockholm, Sweden
Received for publication, February 15, 2000, and in revised form, March 22, 2000
 |
ABSTRACT |
Class III ribonucleotide reductase (RNR) is an
anaerobic glycyl radical enzyme that catalyzes the reduction of
ribonucleotides to deoxyribonucleotides. We have investigated the
importance in the reaction mechanism of nine conserved cysteine
residues in class III RNR from bacteriophage T4. By using site-directed
mutagenesis, we show that two of the cysteines, Cys-79 and Cys-290, are
directly involved in the reaction mechanism. Based on the positioning
of these two residues in the active site region of the known
three-dimensional structure of the phage T4 enzyme, and their
structural equivalence to two cysteine residues in the active site
region of the aerobic class I RNR, we suggest that Cys-290 participates
in the reaction mechanism by forming a transient thiyl radical and that
Cys-79 participates in the actual reduction of the substrate. Our
results provide strong experimental evidence for a similar
radical-based reaction mechanism in all classes of RNR but also
identify important differences between class III RNR and the other
classes of RNR as regards the reduction per se. We also
identify a cluster of four cysteines (Cys-543, Cys-546, Cys-561, and
Cys-564) in the C-terminal part of the class III enzyme, which are
essential for formation of the glycyl radical. These cysteines make up
a CX2C-CX2C motif in
the vicinity of the stable radical at Gly-580. We propose that the four
cysteines are involved in radical transfer between Gly-580 and the
cofactor S-adenosylmethionine of the activating NrdG enzyme
needed for glycyl radical generation.
 |
INTRODUCTION |
Ribonucleotide reductase
(RNR)1 catalyzes the
reduction of ribonucleotides to their corresponding
deoxyribonucleotides. As this is the only way for de novo
synthesis of building blocks for DNA, RNR is an essential constituent
of all living cells. At least three different classes of RNRs can be
distinguished based on their polypeptide composition and cofactor
requirements (1-3). Several prokaryotic organisms encode more than one
class of RNR and in some cases also more than one representative from the same class.
All previously characterized class I and II RNRs operate via a radical
based mechanism, considered to involve one cysteine residue that forms
a transient thiyl radical during catalysis and a cysteine pair that
provides the reducing electrons (4-6). However, the two classes differ
in the way they acquire the thiyl radical. The resting class I RNR
harbors a stable tyrosyl radical close to a diferric-oxo center within
one of its components. The tyrosyl radical interacts with the active
site in the other component via a long range radical transfer pathway.
Class II RNRs require the cofactor adenosylcobalamin that by homolytic
cleavage acts as a thiyl radical generator. Class III RNRs represent a
third variant and harbors a stable glycyl radical within the so-called NrdD component that also harbors the active site region. An activating component, the 4Fe-4S NrdG protein, has the ability to generate the
glycyl radical in NrdD via cleavage of the cofactor AdoMet (7-9).
Class III RNR is an anaerobic enzyme, and the glycyl radical is
extremely sensitive to oxygen. In the recently deduced
three-dimensional structure of a class III enzyme from bacteriophage
T4, only two cysteine residues were encountered in the active site
region (10).
The radical generation procedure of class III RNRs is similar to that
of pyruvate formate-lyase (PFL), a key enzyme in anaerobic glucose
metabolism (11). An activating iron-sulfur protein cleaves AdoMet to
generate a glycyl radical in PFL (12, 13). Two vicinal cysteines,
Cys-418 and Cys-419, are crucial for catalysis, and both are capable of
forming a transient thiyl radical (14-16). Recently, other proteins
have also been suggested to harbor a glycyl radical (17, 18), making
glycyl radical enzymes a distinct group of proteins (19).
Despite the lack of significant overall amino acid sequence
similarities between class III RNRs on the one hand and class I and II
RNRs on the other hand, or between class III RNRs and PFL enzymes, the
catalytic cores of T4 class III RNR, protein R1 of class I RNR from
Escherichia coli, and E. coli PFL are strikingly similar (10, 16, 19, 20). Interestingly, Cys-290 in the class III
enzyme is in a position corresponding to the active site residues
Cys-439 in the R1 structure (Fig. 1) and
Cys-419 in the PFL structure. Cys-439 in R1 is the residue proposed to form the transient thiyl radical during catalysis of RNR. Additionally, Cys-79 from the class III enzyme is in a corresponding position to
Cys-225 in R1, the residue in class I RNR that together with Cys-462
forms the redox active cysteine pair mentioned above (Fig. 1). Cys-462
in the class I structure has no cysteine counterpart in the class III
RNR. These structural similarities suggest that Cys-290 in class III
RNR could have the same proposed function as Cys-439 in the class I
reaction mechanism, but it also suggests that the reaction mechanisms
are different as regards Cys-79 in class III RNR and the redox active
Cys-225-Cys-462 pair in the class I enzyme.

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 1.
Comparisons of the active sites of class III
and class I RNR. A, active site region of bacteriophage
T4 NrdD with GDP substrate modeled from active site region of E. coli protein R1 (10). Conserved residues Cys-79, Cys-290, and
Asn-311 have been indicated. B, active site region of
E. coli protein R1 cocrystallized with GDP (43). Conserved
residues Cys-225, Cys-439, and Cys-462 are indicated.
|
|
We have earlier used site-directed mutagenesis to identify Gly-580 in
phage T4 class III RNR as the site of the stable glycyl radical (21).
In this work we have used the same approach to identify cysteine
residues involved in the reaction mechanism of the T4 class III enzyme.
Alignment of available class III RNR sequences identified five
invariant, one highly conserved, and three moderately conserved
cysteine residues (cf. Table I). We show that six of these
cysteine residues are essential for class III RNR function. Cys-79 and
Cys-290 are directly involved in catalysis, whereas a cluster of four
cysteine residues (Cys-543, Cys-546, Cys-561, and Cys-564) in the
C-terminal part of the enzyme is involved in the radical generation
mechanism. We propose that Cys-290 forms a transient thiyl radical
corresponding to Cys-439 in the class I RNR, which suggests that the
initiation of the reaction for all three RNR classes is similar. In
addition, we propose that the C-terminal cysteine cluster is involved
in the radical transfer between AdoMet and the stable radical position at Gly-580 in the T4 enzyme.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Oligonucleotides used for site-directed
mutagenesis and sequencing were synthesized by Scandinavian Gene
Synthesis AB, Sweden. Restriction enzymes were from Amersham Pharmacia
Biotech, New England Biolabs, or Roche Molecular Biochemicals.
Chemicals were from Sigma, Saveen, and Amersham Pharmacia Biotech.
Bacterial Strains--
E. coli CJ236
(dut-1, ung-1, thi-1,
relA1/pCJ105), E. coli MV1190 (
(lac-proAB), thi, supE,
(srl-recA)306::Tn10/F'traD36, proAB, lacIqZ
M15), E. coli JM109(DE3) endA1, recA1,
gyrA96, thi, hsdR17, (rK
, mK+), relA1,
supE44,
(lac-proAB), [F', traD36,
proAB, lacIqZ
M15],
(DE3),
E. coli C1-a, a wild-type, prototrophic strain.
Plasmids--
Plasmids pET29T4nrdD and pET21aT4nrdG were
described previously (21). Plasmid pEE1010 containing the gene for
ferredoxin (flavodoxin) NADP+ reductase (22) was a kind
gift from Vera Bianchi and Elisabeth Haggård-Ljungquist. The
expression plasmid pDH1 for flavodoxin (23) was a kind gift from Peter Reichard.
Oligonucleotide-directed Mutagenesis--
All mutants were
constructed with the Kunkel method (24, 25) using the Mutagene phagemid
in vitro mutagenesis kit (version 2) as described previously
(21). The mutagenic oligonucleotides also contained the insertion or
deletion of a restriction enzyme cleavage site to facilitate the
screening for mutants. The primers (and within parentheses the
screening restriction enzyme) used for each mutation were as follows:
C79S, 5'-d(TACTAAACAGCTATTAGTAAATG)-3' (AluI); C260S,
5'-d(TTTTGCTTGCGGACTCTAGAGCA)-3'
(HhaI); C290S,
5'-d(AGAAACTACGGAACCCATCGGA)-3'
(NlaIV); C453S, 5'-d(CTGTATCGAGCTTAGAGAAGCGATA)-3'
(DdeI); C543S, 5'-d(CCACATGTAAAGCTTTTATCTACTG)-3'
(AluI); C546S,
5'-d(GGGTACTTCCAGATGTAAAACAT)-3' (AflIII); C561S,
5'-d(CACAAATAGAAGAAACAAATCCG)-3'
(MboII); C564S,
5'-CAGTTTCTCCAGAAATAGAACAA-3' (BpmI);
C579S, 5'-CCAAATAACCAGATGTTCTTCTT-3' (AflIII). The mismatching bases are shown in bold, and
the changed codon is underlined. All mutant plasmids were confirmed by
sequencing using an ABI Prism Cycle sequencing kit from Perkin-Elmer.
The analyzing gels were run by Katarina Gell at CMB, Karolinska
Institute, Sweden.
Oxygen-dependent Cleavage--
JM109(DE3) strains
containing wild-type or mutant pET29T4nrdD (kanamycinR)
plasmids and the wild-type pET21aT4nrdG plasmid
(ampicillinR) were grown aerobically in LB medium
supplemented with 35 µg/ml kanamycin and 100 µg/ml carbenicillin.
The cultures were grown until the A640 reached
0.5 and were then induced with
isopropyl-1-thio-
-D-galactopyranoside (IPTG; final
concentration 1 mM). Samples of 0.5 absorbance units were
withdrawn immediately before induction and after 3 h of induction. The samples were analyzed by SDS-PAGE on a 12.7% gel and stained with
Coomassie Brilliant Blue. The gel was then densitometrically scanned,
and the bands were quantified using the software ImageQuant from
Molecular Dynamics. In Fig. 2, below the
lanes, the extent of truncation is shown as percent NrdD', which is the
amount of NrdD' divided by the sum of NrdD and NrdD'.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 2.
Oxygen-dependent cleavage of
NrdD. Wild-type or mutant NrdD were coexpressed together with
NrdG. Samples were withdrawn and analyzed on a 12.7% SDS-PAGE gel.
Uninduced shows a wild-type NrdD sample before induction
with IPTG; this is the background of the E. coli cells. The
remaining sample lanes show NrdD wild-type and the mutants (as
indicated in the figure) after 3 h of induction. LMW is
a low molecular weight marker (Amersham Pharmacia Biotech); the
molecular weight of the marker proteins is indicated in kDa. NrdD and
the truncated form, called NrdD', are indicated by arrows.
The bands were quantified after densitometric scanning, and the
background from lane 1 was subtracted. At the
bottom of the lanes, the percentage of cleavage is shown (% NrdD'), which is the ratio of NrdD' divided by the sum of NrdD and
NrdD'.
|
|
Anaerobic Expression, Anaerobic Crude Extract Preparation, EPR
Sample Preparation, and Activity Assays--
For anaerobic growth and
anaerobic crude extract preparations of wild-type or mutant NrdD, and
of wild-type NrdG, the procedure described in Ref. 21 was followed.
Anaerobic activity assays and EPR measurements in anaerobic crude
extracts are also described in Ref. 21.
Aerobic Expression and Purification of NrdD--
Wild-type and
mutant proteins were prepared as described previously (26). In brief,
the NrdD protein was expressed aerobically using IPTG induction. After
harvesting, the frozen cells were disintegrated in an X-press (from
BIOX), extracted in 20 mM Tris-HCl, pH 8.0, 1 mM DTT, and soluble proteins were batch-purified by streptomycin sulfate (1% final concentration) and ammonium sulfate (40% final concentration) precipitations. Further purification was
achieved using hydrophobic interaction chromatography with butyl-Sepharose 4 Fast Flow media from Amersham Pharmacia Biotech.
Aerobic Expression and Crude Extract Preparation of
NrdG--
The JM109(DE3) strain containing the plasmid pET21aT4nrdG
was grown in Luria Broth medium, pH 7.0, supplemented with 50 µg/ml carbenicillin, and deionized water was used. The growth was done in a
10-liter container using a Microferm® fermentor from New Brunswick
Scientific Co. The culture was grown at 30 °C, and when the cells
reached an A640 of 0.6 they were induced with
IPTG (final concentration 0.5 mM), and the temperature was
lowered (typically to 14-19 °C) to avoid formation of inclusion
bodies. After 20 h of induction (A640 = 1.0-1.4) the cells were harvested by centrifugation, and the pellet
was frozen at
80 °C. The frozen pellet was pressed 3-5 times in
an X-press and extracted with 100 mM Tris-HCl, pH 7.6, 5 mM DTT in a blender. Nucleic acids were removed by
precipitation with streptomycin sulfate to a final concentration of
1%. The proteins were then precipitated with 40% ammonium sulfate and desalted over a NAP column containing Sephadex® G-25 medium from Amersham Pharmacia Biotech. The NrdG content was typically ~10% of
the total protein fraction, as estimated from SDS-PAGE analyses. The
desalted crude extract preparation was later used for EPR samples and
enzymatic activity assays.
Aerobic Expression and Purification of Flavodoxin
Reductase--
The protocol from Ref. 22 was followed with some minor
changes. The C1-a strain containing the plasmid pEE1010 was grown to
stationary phase for expression of flavodoxin reductase, and the cells
were then lysed with lysozyme treatment and freeze-thawing. A
Superose-12 column was used to purify the 29-kDa protein, and its
flavin-related absorption spectrum was found identical to that in Ref.
22.
Aerobic Expression and Purification of Flavodoxin--
The
protocol from D. Hoover was followed. The plasmid pDH1 containing the
gene for flavodoxin was grown in the C1-a strain, and induction was
made with IPTG; the cells were lysozyme-treated and freeze-thawed 3 times; neutralized FMN was added, 1-2 mg/liter culture. A DEAE column
was used to separate the flavodoxin protein as confirmed by SDS-PAGE,
its absorption spectrum, and the
A274/A467 ratio.
Anaerobic Activation and EPR Analyses of Aerobically Purified
Components--
Purified wild-type or mutant NrdD, crude extract
preparation of NrdG, and a mixture containing all the activation
components were flushed separately with argon at 4 °C for 40 min in
order to remove oxygen. They were then transferred to a Forma
Scientific anaerobic glove box where they were mixed and incubated
anaerobically for 45 min at room temperature. The final concentrations
were 37.5 µM pure NrdD, NrdG-containing crude extract (40 mg/ml total protein, ~75 µM NrdG), 30 mM
Tris-HCl, pH 8.0, 30 mM KCl, 5 mM sodium
formate, 5 mM DTT, 1.25 mM NADPH, 18 µM flavodoxin reductase, 6 µM flavodoxin,
and 0.5 mM AdoMet, and the total volume was 160 µl. The
samples were then transferred to EPR tubes, sealed, taken out of the
anaerobic box, and frozen in liquid nitrogen.
X-band EPR measurements were performed at 77 K on a Bruker ESP300
spectrometer using a cold finger Dewar filled with liquid nitrogen.
Double integrals of the EPR signals were determined using the Bruker
software, and the radical content was calculated from the spin
concentration comparing with a Cu2+-EDTA standard and a
known glycyl radical standard.
Anaerobic Activation and Enzymatic Activity Assays of Aerobically
Purified Components--
Purified wild-type or mutant NrdD, crude
extract preparation of NrdG, an activation mixture containing all the
necessary components for generating the glycyl radical, and a substrate
mixture were flushed separately with argon at 4 °C for 40 min to
remove oxygen before transferring them to the anaerobic box. NrdD, NrdG
and the activation mixture were then mixed and incubated at room
temperature for 10 min. The incubation mixture contained 0.12 µM pure NrdD, NrdG-containing crude extract (10 mg/ml
total protein,~20 µM NrdG), 30 mM Tris-HCl,
pH 8.0, 30 mM KCl, 5 mM DTT, 1.25 mM NADPH, 3 µM flavodoxin reductase, 2 µM flavodoxin, and 0.5 mM AdoMet, and the
total volume was 25 µl. After 10 min, 25 µl of substrate mixture was added giving final concentrations of 30 mM Tris-HCl, pH
8.0, 30 mM KCl, 5 mM sodium formate, 5 mM DTT, 20 mM MgCl2, 1 mM dATP, and 5 mM [3H]CTP. Incubation
with substrate was stopped after 20 min by addition of 500 µl of 1 M perchloric acid. A carrier, 50 µl of dCMP, 5 mg/ml, was
added as internal standard to follow recovery during the work-up
procedure. After dephosphorylation to the monophosphate level by
boiling, separation of [3H]dCMP and [3H]CMP was
performed over a Dowex-50 column, and isocratic elution was made with
0.2 M acetic acid. The formed 3H-labeled
product was then quantified in a scintillation counter.
Metal Analyses--
The analyses were made by ICP-AES, plasma
emission spectrometry, or ICP-SMS, plasma mass spectrometry by SGAB
Analytica, Luleå, Sweden. One additional purification step (anionic
mono-Q chromatography) was added prior to analyses. Protein samples
contained 85-90% NrdD as judged from SDS-PAGE analysis and Coomassie
Blue staining.
 |
RESULTS |
Site-directed Mutagenesis--
To test our hypothesis that
cysteine residues are involved in the reaction mechanism of the class
III RNRs, we used site-directed mutagenesis to change conserved
cysteines in the T4 NrdD protein. In all, nine cysteines
(cf. Table I) were separately
mutated to serine in order to abolish the redox function of the SH
group while maintaining the size and the H-bonding capacity of the side chain. Five of these residues (Cys-79, Cys-290, Cys-543, Cys-561, and
Cys-564) are invariant, and one (Cys-546) is highly conserved (Table
I). Four of the C-terminal cysteines make up a
CX2C-CX2C motif, below
denoted the C-terminal cluster. Cys-260 and Cys-453 are only conserved
in 12 of the 19 available NrdD sequences, as is Cys-579, adjacent to
the site of the stable radical at Gly-580 (Table I). During the
expression and purification all mutant Cys
Ser NrdD proteins
behaved like wild type.
Oxygen-dependent Cleavage of Cys
Ser Mutant NrdD
Proteins--
The class III anaerobic RNRs have been shown to undergo
truncation at the site of the glycyl radical when the
radical-containing enzyme is exposed to oxygen (27). A facile in
vivo assay to detect formation of the glycyl radical is to monitor
this truncation of NrdD when coexpressed aerobically with NrdG (21).
This assay was used to monitor whether a glycyl radical is formed or
not in the Cys
Ser mutants. Samples from the coexpressions were analyzed on a SDS-PAGE gel (Fig. 2). The full-length NrdD protein migrates approximately according to its theoretical molecular mass of
68 kDa (21). The truncated form, denoted NrdD', migrates slightly
faster than the full-length NrdD, in good agreement with the
anticipated truncation at Gly-580 ~3 kDa from the C terminus of the
phage T4 NrdD.
The oxygen-dependent cleavage can clearly be seen for the
mutants C79S, C260S, C290S, C453S, and C579S (Fig. 2). As a negative control, the G580A mutant is also shown; oxygen-dependent
cleavage is not possible in this mutant since no radical can be formed at Ala-580 (21). To estimate the extent of truncation, the protein gel
was densitometrically scanned, and the protein bands were quantified.
Samples harvested before induction with IPTG contained an unrelated
protein band that comigrates with truncated NrdD' protein (Fig. 2,
Uninduced). This unrelated protein band was subtracted from
the NrdD' protein band. As can be seen, the truncation occurs in
approximately 60% of the polypeptide chains of wild-type NrdD. The
extent of truncation agrees with the amount of radical per NrdD dimer
(~0.55; cf. Table III) and has earlier been observed for
NrdD from phage T4 and from E. coli (21, 28, 29). The mutants C79S, C260S, C290S, and C453S were truncated to 51-62%, and
the C579S mutant was truncated to 39% (Fig. 2). This result clearly
establishes that a glycyl radical could be formed in these five
mutants. Fig. 2 also shows that no truncation occurs in the four
C-terminal mutants C543S, C546S, C561S, and C564S suggesting that no
glycyl radical could be formed in these mutants.
EPR Measurements and Enzymatic Activity Assays on Anaerobic Crude
Extracts--
Anaerobic crude extracts from the four mutants C79S,
C260S, C290S, and C453S were combined with anaerobically produced
NrdG-containing extracts and incubated with AdoMet to promote
generation of the glycyl radical and were then used for EPR
measurements and enzymatic activity assays. All four mutant proteins
displayed a doublet EPR signal with the characteristics of the glycyl
radical of wild-type NrdD (Fig.
3A). The relative radical
contents compared with wild-type NrdD are shown in Table
II. As can be seen, the mutants C79S, C260S, and C453S have radical contents comparable to wild type; the
mutant C260S has an even higher radical content than wild-type NrdD.
The mutant C290S has roughly half the radical content of wild-type
NrdD.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 3.
EPR spectra of NrdD:NrdG mixtures.
A, anaerobic crude extracts of wild-type or mutant NrdD were
mixed with anaerobic crude extract of NrdG and incubated anaerobically
together with AdoMet for 45 min. Samples for EPR measurement were
transferred to EPR tubes, sealed with a rubber top, and frozen in
liquid nitrogen. EPR conditions were as follows: microwave power, 10 microwatts; modulation amplitude, 0.16 mT; receiver gain, 1 × 106; 4 scans. The arrow indicates a g
value of 2.004. B, mixtures of purified NrdD and crude
extract of NrdG. Aerobically expressed purified wild-type or mutant
NrdD was mixed with aerobically expressed crude extract of NrdG and
activated anaerobically. Samples for EPR measurement were transferred
to EPR tubes, sealed with a rubber top, and frozen in liquid nitrogen.
EPR conditions were as follows: microwave power, 8.5 microwatts;
modulation amplitude, 0.16 mT; receiver gain, 5 × 105; 1 scan. The arrow indicates a g
value of 2.004.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Specific activity and radical content for anaerobic crude extracts of
wild-type NrdD and the putative active site cysteine mutants
|
|
Interestingly, the enzymatic activity assays showed that C79S and C290S
had completely lost enzymatic activity (Table II). Given the fact that
a glycyl radical was formed in these mutants (Fig. 3A), the
two cysteine residues must be important for a step occurring after the
generation of the glycyl radical, plausibly the reaction mechanism.
This is the first experimental evidence for the importance of Cys-79
and Cys-290 in the reaction mechanism of the class III RNRs.
The mutants C260S and C453S had enzymatic activities comparable to wild
type showing that these mutants are not involved in the reaction
mechanism. The C260S mutant has an even higher activity than wild-type
NrdD, which was also reflected in a higher radical content.
EPR Measurements and Enzymatic Activity Assays on Purified NrdD
Proteins--
In an attempt to obtain a system with pure proteins and
a distinct activation procedure, we set out to express and purify NrdD
and NrdG separately. Unfortunately, the overexpressed NrdG protein had
a severe tendency to form inclusion bodies, and the resulting purified
NrdG protein was highly unstable during assay conditions. We therefore
resorted to an activation procedure using purified NrdD, crude extract
of NrdG, and purified flavodoxin system (flavodoxin and flavodoxin
reductase), see "Experimental Procedures." All protein fractions
were prepared aerobically and then made anaerobic by argon flushing
before the activation procedure. In this set of assays, the NrdD
concentration was ~300-fold higher in the EPR measurements as
compared with the enzymatic activity measurements, and the NrdG:NrdD
ratios were 2 and 100-150, respectively. Accordingly, we used
activation times of 45 min for EPR experiments and 10 min for
activity measurements.
Activity assays of the four mutants C79S, C260S, C290S, and C453S
confirmed the former results that C79S and C290S lack enzymatic activity and that C260S and C453S have activities comparable to wild-type NrdD (Table III). Again, C260S
had slightly higher enzymatic activity than wild-type NrdD (Tables II
and III). The C453S mutant had 68% of wild-type activity compared with
75% for the anaerobic crude extracts (Tables II and III).
For the mutants C79S and C260S, the EPR measurements gave the same
results as for the anaerobic crude extracts (Fig. 3A)
showing radical contents comparable to wild-type NrdD (Fig.
3B). The relative radical content of the C453S mutant was
much lower than in the anaerobic crude extracts (Tables II and III).
However, as this mutant has almost full enzymatic activity (Table III),
it is plausible that these EPR conditions are suboptimal compared with
the results from the anaerobic crude extracts.
Unexpectedly, no glycyl radical could be detected by EPR in the
purified C290S sample (Fig. 3B). This particular experiment could thus not conclusively distinguish whether the lack of enzymatic activity was due to a failure in forming the glycyl radical or a cause
of the mutation itself. However, since the two previous assays (Figs. 2
and 3A) showed glycyl radical formation in C290S, it
indicates that the glycyl radical in the purified mutant C290S protein
is not as stable as in wild-type NrdD.
Also the mutant C579S seemed to be less stable in assays with purified
protein as compared with crude extract assays (data not shown). Even
though this mutant had no detectable radical, its low but significant
enzyme activity (Table III) suggests that some glycyl radical was
formed (cf. Fig. 2). The detection limit of our EPR assay is
about 0.5 µM glycyl radical, corresponding to ~2% of
the wild-type radical content. As for the C290S mutant, C579S could
form a glycyl radical as judged from the oxygen-dependent cleavage assay (Fig. 2).
The C-terminal Cysteine Cluster--
The cysteines of the
C-terminal cluster Cys-543, Cys-546, Cys-561, and Cys-564 had no
detectable glycyl radical by EPR and no enzymatic activity (Table III).
The lack of glycyl radical formation confirmed the results from the
oxygen-dependent cleavage assay (Fig. 2). The lack of
enzymatic activity is logical since a glycyl radical is required
for enzymatic activity.
One obvious explanation for the inability to form a glycyl radical
would be that the complex between NrdD and NrdG was unable to form in
these four mutant proteins. Generation of the glycyl radical in the
NrdD subunit is promoted by the FeS center of the NrdG subunit (7, 9,
30). We therefore coexpressed each NrdD mutant with wild-type NrdG and
purified the crude extracts over butyl-Sepharose columns. Similar
conditions were used for purification of the holoenzyme complex
NrdD(G580A)-NrdG(wild-type) (10). Fig. 4
shows that all four mutants, C543S, C546S, C561S, and C564S, were able
to bind the NrdG subunit and that the relative yields of NrdD and NrdG
components were comparable to that seen for the
NrdD(G580A)-NrdG(wild-type) complex (21). This rules out the
possibility that the lack of glycyl radical in any of these Cys
Ser
mutants is due to impaired binding of the NrdG subunit and suggests
that the three-dimensional structures of these mutants are
unchanged.

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 4.
SDS-PAGE analysis of cochromatographing NrdD
and NrdG components. The samples contain C543S (lane
1), C546S (lane 2), C561S (lane 3), C5645
(lane 4), and wild-type NrdD (lane 5), in all
cases mixed with excess NrdG. The migration of the NrdD and NrdG
polypeptides is indicated. M denotes a marker protein
mixture, molecular masses of 94, 67, 43, 30, 20.1 and 14.4 kDa.
|
|
Metal Analyses--
To investigate further the role of the
C-terminal cysteine cluster, we performed a full transition metal
analysis of wild-type NrdD and of an aliquot of the complex
NrdD(G580A)-NrdG(wild-type) used for crystallizations. In parallel,
NrdD(G580A) and the sample buffer were used as controls. None of the
protein samples had any significant amounts of metal ions associated to
them (data not shown).
 |
DISCUSSION |
In this study we provide the first biochemical evidence that
multiple cysteine residues are required for the generation of the
stable glycyl radical and for enzymatic activity in the class III RNR
from phage T4. Multiple cysteine residues have earlier been shown to be
involved in the reaction mechanism of class I and II RNRs (4-6).
The reaction mechanisms of class I and II RNRs are very similar and are
based on radical chemistry. Three active site cysteines are responsible
for nucleotide reduction, and two C-terminal cysteines interact with a
physiological protein reductant (1). The two systems differ mainly in
the way the radical chemistry is initiated. Implications for a common
reaction mechanism for all RNR classes stem from reactions with
2'-azido substrate analogues. 2'-Azido-CDP is a mechanism-based
inhibitor that irreversibly destroys the tyrosyl radical of class I RNR
and forms a new nitrogen-centered radical in a half-turnover reaction
(31-33). The nitrogen-centered radical has also been observed in
incubations of 2'-azido-CTP and a class II RNR (34). In this sense, the
reaction mechanism of class III RNR is similar to that of class I and
II RNRs. Incubations of E. coli class III RNR with
2'-azido-CTP led to destruction of the glycyl radical (35), and similar
results have been obtained for class III RNR from phage
T4.2 On the other hand,
differences in reaction mechanisms between class III RNRs and class
I/II RNRs were expected, as class III RNRs use formate as reductant and
are independent of protein-derived reductants, like "redoxins"
(36). The recently solved three-dimensional structure of T4 NrdD
corroborated this as only two conserved cysteines were localized to the
active site of the class III RNR (10).
We have investigated the importance of several highly conserved
cysteine residues in the reaction mechanism of the class III RNRs by
site-directed mutagenesis. In one set of experiments we show that
engineering of Cys-79 and Cys-290 renders catalytically inert protein,
whereas engineering of Cys-260 and Cys-453 does not. The invariant
residues Cys-79 and Cys-290 are localized to the active site region of
T4 NrdD. By using the photoaffinity labeling technique, Olcott et
al. (26) independently identified Cys-290 of T4 NrdD as part of a
nucleotide-binding site. Cys-260 and Cys-453, on the other hand, are
not absolutely conserved among class III RNRs (cf. Table I)
and are located 21 and 15 Å from the active site region of T4 NrdD
(10).
The identification of only two catalytically essential cysteines in the
active site region of T4 NrdD confirms that the reaction mechanism of
class III RNR is not identical to that of class I and II RNRs. However,
extensive three-dimensional similarities between class I and III RNRs
suggest that Cys-290 of T4 NrdD is homologous to Cys-439 of E. coli R1 (10, 20). It has therefore been proposed that Cys-290,
whose sulfur atom is 4.0 Å from the 3' carbon atom of the modeled
substrate, forms a transient thiyl radical that initiates catalysis by
abstracting the 3'-H atom of the substrate (10), a suggestion that is
fully corroborated by our results. Interestingly, Cys-290 of T4 NrdD
and Cys-439 of R1 could also be aligned to Cys-419 of PFL, one of the
cysteines shown to form a transient thiyl radical in the PFL system
(14-16). Recent results for the class I RNR indicate involvement of a
conserved carboxylate side chain in the steps following the abstraction of the 3'-hydrogen of the substrate (37-39). No direct counterpart of
this residue is found in the class III RNR, instead formate may take
this role.
Comparison of the class I and III structures shows that Cys-79 in T4
NrdD has a homologous position to Cys-225 in E. coli R1 (10,
20). The sulfur atom of Cys-79 is positioned 4.1 Å from the 2'-OH of
the modeled substrate (10). In the class I reaction mechanism, Cys-225
and the conserved Cys-462 are the immediate reductants of the
2'-position. However, there is no cysteine counterpart in T4 NrdD of
Cys-462 in E. coli class I RNR. Instead, one formate
molecule is oxidized to CO2 per molecule of reduced
substrate in the class III mechanism (36). Based on these observations,
we propose that Cys-79, together with formate, participates in later
steps of the reaction mechanism and at some stage forms a transient
thiyl radical. Formate is a small molecule that could easily access the
active site. Most likely, it participates in the reaction mechanism as
a carbon dioxide radical.
In another experiment, we engineered Cys-579, next to the site of the
stable radical at Gly-580 in T4 NrdD. Cys-579 is a highly conserved
residue, present in 12 out of 19 class III sequences (Table I). The
C579S mutant had a low enzymatic activity (7% of wild-type activity;
Table III) and approximately two-thirds of the wild-type glycyl radical
content (Fig. 2). The corresponding C680S mutation in the class III RNR
from E. coli was shown to have 14% of the wild-type
activity and 20% of the wild-type radical content (29). We have thus
confirmed that the cysteine residue immediately preceding the glycyl
radical residue in class III RNRs is not directly involved in the
radical formation or the reaction mechanism. However, its proximity to
the glycyl radical may make it particularly susceptible to mutational
changes. Cys-579 could play a structural role during generation and
stabilization of the glycyl radical or when the Gly-580·
Cys-290· transition occurs.
In a third set of experiments, we have shown that the four
C-terminal cysteines (Cys-543, Cys-546, Cys-561, and
Cys564), which make up the cluster motif
CX2C-CX2C, are essential
for formation of the glycyl radical (Fig. 2). The cysteine cluster is
reminiscent of a metal-binding motif, e.g. an iron-cysteine
center or a zinc finger. We were, however, unable to identify any metal
ions associated with the protein. One possibility is that bound metal
ions were lost during purification of the protein. Even though the
distance between the C-terminal cysteines and the glycyl radical is
long,3 the C-terminal
cysteine cluster could have a structurally important role in radical
generation. Initially, it was suggested that the NrdD component of
E. coli class III RNR contained an FeS cluster (40), but
this metal site was later shown to be located in the NrdG subunit (30).
The functional NrdG metal site is now known to be a
Fe4S4+/Fe4S42+
redox center that is easily interconverted to redox-inactive Fe3S4+/0 and
Fe2S22+ forms (9, 41, 42). AdoMet
interacts with the FeS center in the NrdG subunit, whereby a
5'-deoxyadenosyl radical is transiently formed (7). Subsequent radical
transfer between the deoxyadenosyl radical and the glycine at the
radical site in NrdD generates the stable glycyl radical. Considering
that the Cys
Ser mutants of the C-terminal cluster behave like
wild-type NrdD in NrdD-NrdG complex formation and that the activating
NrdG is a wild-type enzyme, we suggest that the C-terminal cysteine
cluster is directly involved in formation of the glycyl radical,
e.g. by participating in radical transfer between the
deoxyadenosyl radical and Gly-580. However, at this stage we cannot
exclude that the C-terminal cysteine cluster forms a structurally
important fold for the radical transfer. The structure of the
C-terminal part of T4 NrdD, including the cysteine cluster, was not
deducible in the initial electron density map (10), indicating that
this part of NrdD may be rather flexible.
To summarize, we have shown that Cys-79 and Cys-290 are essential
components of the reaction mechanism of the class III RNR from phage
T4, and we propose that Cys-290 forms a transient thiyl radical that
initiates the reaction mechanism and that Cys-79 mediates the
formate-dependent reduction of the substrate. We have also
shown that the four cysteines of the C-terminal cluster, Cys-543,
Cys-546, Cys-561, and Cys-564, are required for formation of the glycyl
radical. We propose that these residues, which are in a flexible part
of the NrdD protein, are involved in radical transfer between AdoMet
and Gly-580.
 |
ACKNOWLEDGEMENTS |
We thank Bobby Arash for help with
construction of the C-terminal mutants and Maria Lindström for
help with expressing them. We also thank Sabrina Bodevin and Ulla-Maja
Petersen for scientific discussions and suggestions about
this manuscript.
 |
FOOTNOTES |
*
This study was supported by grants from the Swedish Cancer
Foundation and the Swedish Foundation for Strategic Research.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 46-8-164150;
Fax: 46-8-152350; E-mail: bitte@molbio.su.se.
Published, JBC Papers in Press, March 27, 2000, DOI 10.1074/jbc.M001278200
2
J. Andersson, M. Sahlin, and B.-M.
Sjöberg, unpublished observations.
3
D. Logan, personal communication.
 |
ABBREVIATIONS |
The abbreviations used are:
RNR, ribonucleotide
reductase;
AdoMet, S-adenosylmethionine;
DTT, dithiothreitol;
EPR, electron paramagnetic resonance;
IPTG, isopropyl-1-thio-
-D-galactopyranoside;
NrdD', truncated
form of NrdD;
PFL, pyruvate formate-lyase;
PAGE, polyacrylamide gel
electrophoresis.
 |
REFERENCES |
| 1.
|
Sjöberg, B.-M.
(1997)
Struct. Bonding
88,
139-173
|
| 2.
|
Jordan, A.,
and Reichard, P.
(1998)
Annu. Rev. Biochem.
67,
71-98
|
| 3.
|
Stubbe, J.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
2723-2724
|
| 4.
|
Åberg, A.,
Hahne, S.,
Karlsson, M.,
Larsson, A.,
Ormö, M.,
Åhgren, A.,
and Sjöberg, B.-M.
(1989)
J. Biol. Chem.
264,
12249-12252
|
| 5.
|
Mao, S. S.,
Holler, T. P., Yu, G. X.,
Bollinger, J. M.,
Booker, S.,
Johnston, M. I.,
and Stubbe, J.
(1992)
Biochemistry
31,
9733-9743
|
| 6.
|
Booker, S.,
Licht, S.,
Broderick, J.,
and Stubbe, J.
(1994)
Biochemistry
33,
12676-12685
|
| 7.
|
Ollagnier, S.,
Mulliez, E.,
Schmidt, P. P.,
Eliasson, R.,
Gaillard, J.,
Deronzier, C.,
Bergman, T.,
Gräslund, A.,
Reichard, P.,
and Fontecave, M.
(1997)
J. Biol. Chem.
272,
24216-24223
|
| 8.
|
Ollagnier, S.,
Meier, C.,
Mulliez, E.,
Gaillard, J.,
Schuenemann, V.,
Trautwein, A.,
Mattioli, T.,
Lutz, M.,
and Fontecave, M.
(1999)
J. Am. Chem. Soc.
121,
6344-6350
|
| 9.
|
Tamarit, J.,
Mulliez, E.,
Meier, C.,
Trautwein, A.,
and Fontecave, M.
(1999)
J. Biol. Chem.
274,
31291-31296
|
| 10.
|
Logan, D. T.,
Andersson, J.,
Sjöberg, B.-M.,
and Nordlund, P.
(1999)
Science
283,
1499-1504
|
| 11.
|
Knappe, J.,
and Wagner, A. F. V.
(1995)
Methods Enzymol.
258,
343-362
|
| 12.
|
Wagner, A. F.,
Frey, M.,
Neugebauer, F. A.,
Schäfer, W.,
and Knappe, J.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
996-1000
|
| 13.
|
Frey, M.,
Rothe, M.,
Wagner, A. F.,
and Knappe, J.
(1994)
J. Biol. Chem.
269,
12432-12437
|
| 14.
|
Knappe, J.,
Elbert, S.,
Frey, M.,
and Wagner, A. F. V.
(1993)
Biochem. Soc. Trans.
21,
731-734
|
| 15.
|
Parast, C. V.,
Wong, K. K.,
Kozarich, J. W.,
Peisach, J.,
and Magliozzo, R. S.
(1995)
Biochemistry
34,
5712-5717
|
| 16.
|
Becker, A.,
FritzWolf, K.,
Kabsch, W.,
Knappe, J.,
Schultz, S.,
and Wagner, A. F. V.
(1999)
Nat. Struct. Biol.
6,
969-975
|
| 17.
|
Hesslinger, C.,
Fairhurst, S. A.,
and Sawers, G.
(1998)
Mol. Microbiol.
27,
477-492
|
| 18.
|
Leuthner, B.,
Leutwein, C.,
Schulz, H.,
Horth, P.,
Haehnel, W.,
Schiltz, E.,
Schagger, H.,
and Heider, J.
(1998)
Mol. Microbiol.
28,
615-628
|
| 19.
|
Eklund, H.,
and Fontecave, M.
(1999)
Structure
7,
R257-R262
|
| 20.
|
Uhlin, U.,
and Eklund, H.
(1994)
Nature
370,
533-539
|
| 21.
|
Young, P.,
Andersson, J.,
Sahlin, M.,
and Sjöberg, B.-M.
(1996)
J. Biol. Chem.
271,
20770-20775
|
| 22.
|
Bianchi, V.,
Reichard, P.,
Eliasson, R.,
Pontis, E.,
Krook, M.,
Jörnvall, H.,
and Haggård-Ljungquist, E.
(1993)
J. Bacteriol.
175,
1590-1595
|
| 23.
|
Bianchi, V.,
Eliasson, R.,
Fontecave, M.,
Mulliez, E.,
Hoover, D. M.,
Matthews, R. G.,
and Reichard, P.
(1993)
Biochem. Biophys. Res. Commun.
197,
792-797
|
| 24.
|
Kunkel, T. A.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
488-492
|
| 25.
|
Kunkel, T. A.,
Roberts, J. D.,
and Zakour, R. A.
(1987)
Methods Enzymol.
154,
367-382
|
| 26.
|
Olcott, M. C.,
Andersson, J.,
and Sjöberg, B.-M.
(1998)
J. Biol. Chem.
273,
24853-24860
|
| 27.
|
King, D. S.,
and Reichard, P.
(1995)
Biochem. Biophys. Res. Commun.
206,
731-735
|
| 28.
|
Sun, X. Y.,
Eliasson, R.,
Pontis, E.,
Andersson, J.,
Buist, G.,
Sjöberg, B.-M.,
and Reichard, P.
(1995)
J. Biol. Chem.
270,
2443-2446
|
| 29.
|
Sun, X. Y.,
Ollagnier, S.,
Schmidt, P. P.,
Atta, M.,
Mulliez, E.,
Lepape, L.,
Eliasson, R.,
Gräslund, A.,
Fontecave, M.,
Reichard, P.,
and Sjöberg, B.-M.
(1996)
J. Biol. Chem.
271,
6827-6831
|
| 30.
|
Ollagnier, S.,
Mulliez, E.,
Gaillard, J.,
Eliasson, R.,
Fontecave, M.,
and Reichard, P.
(1996)
J. Biol. Chem.
271,
9410-9416
|
| 31.
|
Sjöberg, B.-M.,
Gräslund, A.,
and Eckstein, F.
(1983)
J. Biol. Chem.
258,
8060-8067
|
| 32.
|
van der Donk, W. A.,
Stubbe, J.,
Gerfen, G. J.,
Bellew, B. F.,
and Griffin, R. G.
(1995)
J. Am. Chem. Soc.
117,
8908-8916
|
| 33.
|
Behravan, G.,
Sen, S.,
Rova, U.,
Thelander, L.,
Eckstein, F.,
and Gräslund, A.
(1995)
Biochim. Biophys. Acta
1264,
323-329
|
| 34.
|
Ashley, G. W.,
Lawrence, C. C.,
Stubbe, J.,
and Robins, M. J.
(1997)
Tetrahedron
53,
12005-12016
|
| 35.
|
Eliasson, R.,
Pontis, E.,
Eckstein, F.,
and Reichard, P.
(1994)
J. Biol. Chem.
269,
26116-26120
|
| 36.
|
Mulliez, E.,
Ollagnier, S.,
Fontecave, M.,
Eliasson, R.,
and Reichard, P.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
8759-8762
|
| 37.
|
Persson, A. L.,
Eriksson, M.,
Katterle, B.,
Pötsch, S.,
Sahlin, M.,
and Sjöberg, B.-M.
(1997)
J. Biol. Chem.
272,
31533-31541
|
| 38.
|
Persson, A. L.,
Sahlin, M.,
and Sjöberg, B.-M.
(1998)
J. Biol. Chem.
273,
31016-31020
|
| 39.
|
Lawrence, C. C.,
Bennati, M.,
Obias, H. V.,
Bar, G.,
Griffin, R. G.,
and Stubbe, J.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
8979-8984
|
| 40.
|
Mulliez, E.,
Fontecave, M.,
Gaillard, J.,
and Reichard, P.
(1993)
J. Biol. Chem.
268,
2296-2299
|
| 41.
|
Mulliez, E.,
Ollagnier-de Choudens, S.,
Meier, C.,
Cremonini, M.,
Luchinat, C.,
Trautwein, A. X.,
and Fontecave, M.
(1999)
J. Biol. Inorg. Chem.
4,
614-620
|
| 42.
| Liu, A., and Gräslund, A. (2000) J. Biol. Chem.
275, in press
|
| 43.
|
Eriksson, M.,
Uhlin, U.,
Ramaswamy, S.,
Ekberg, M.,
Regnström, K.,
Sjöberg, B.-M.,
and Eklund, H.
(1997)
Structure
5,
1077-1092
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. T. Logan, E. Mulliez, K.-M. Larsson, S. Bodevin, M. Atta, P. E. Garnaud, B.-M. Sjoberg, and M. Fontecave
Bioinorganic Chemistry Special Feature: A metal-binding site in the catalytic subunit of anaerobic ribonucleotide reductase
PNAS,
April 1, 2003;
100(7):
3826 - 3831.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Padovani, E. Mulliez, and M. Fontecave
Activation of Class III Ribonucleotide Reductase by Thioredoxin
J. Biol. Chem.,
March 23, 2001;
276(13):
9587 - 9589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Andersson, S. Bodevin, M. Westman, M. Sahlin, and B.-M. Sjoberg
Two Active Site Asparagines Are Essential for the Reaction Mechanism of the Class III Anaerobic Ribonucleotide Reductase from Bacteriophage T4
J. Biol. Chem.,
October 26, 2001;
276(44):
40457 - 40463.
[Abstract]
[Full Text]
[PDF]
|
 |
|